Immediate EU-wide measures are needed to ensure the supply of medicines, according to off-patent industry association Medicines for Europe, which has also called for clear regulatory guidance and scenario planning to address the challenges posed by the coronavirus outbreak.
Three key actions are needed to ensure the supply of medicines in Europe as the region grapples with the effects of the coronavirus outbreak, according to Medicines for Europe.
The off-patent industry association has made “three key requests” – for immediate and urgent actions to ensure supply; regulatory guidance;...
Doubling down on the launch of its Stelara biosimilar Pyzchiva in Europe last year, Sandoz has just released an autoinjectable version of the drug, with the aim to offer a more convenient option for ustekinumab patients.
The UK struck three international agreements in May, but two of them failed to include medicines or provide any benefits for the pharmaceutical sector. Medicines UK warned that protecting medicine supplies should be of the same importance as defense.
Sun readies US debut of Leqselvi for alopecia areata, while PD-L1 inhibitor Unloxcyt is in the line up once the Checkpoint Therapeutics deal is completed. Management also discusses limited clarity on President Trump’s most favored nation pricing push, pipeline tweaks and M&A outlook.
